Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene
Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug bisantrene
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No Corporate Spotlight currently available.